from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3730c/-

LFCtreatmentdescriptionclass of inhibitor

-0.183

Amikacinug/mL Amikacintranslation

0.036

Cap5-10ug/mL Capreomycintranslation

-0.757

Rox10-50 ug/mL Roxithromycintranslation

0.043

SM2-5 ug/mL Streptomycintranslation

-0.329

Tet5-10 ug/mL Tetracyclinetranslation

0.076

Rif0.2-5ug/mL Rifampicintranscription

-0.462

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.348

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.425

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.610

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.015

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.343

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.630

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.513

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.341

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.277

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.036

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

4.251

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.286

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.280

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.495

KCN5-20 ug/mL Potassium cyaniderespiration

-0.200

NaN30.2-2 mM Sodium aziderespiration

0.113

Nigericin50 uM Nigericinrespiration

-0.645

TRC10-150 ug/mL Triclosanrespiration

-0.165

TRZ10-25 ug/mL Thioridazinerespiration

-0.680

Valinomycin0.5-10 uM Valinomycinrespiration

-0.772

ZnSO42 mM ZnSO4respiration

0.246

menadione6-10 ug/mL Menadionerespiration

0.113

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.127

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.064

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.455

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.754

NRP_1Non-replicating persistence stage 1dosRassociated

0.049

Amp0.2mg/mL AmpicillincellWall

-0.225

Cephalexin20-100 ug/mL CephalexincellWall

0.160

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.242

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.380

EMB10-20 ug/mL EthambutolcellWall

-0.061

Eta12-40 ug/mL EthionamidecellWall

-0.041

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.028

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.526

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.635

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.326

BZA0.12 mg/mL BenzamidearomaticAmides

-0.424

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.196

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.163

H2O24 mM hydrogen peroxideDNAdamaging

-0.207

Levo10 ug/mL LevofloxacinDNAdamaging

0.004

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.905

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.083

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.078

UVUV-irradiationDNAdamaging

-0.399

ARP41-4 ug/mL Antitubercular compound ARP4?

0.042

Antimycin12.5-50 ug/mL Antimycin A?

0.319

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.130

PA_110-50 ug/mL Antitubercular compound PA-1?

0.191

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.244

PA8240.2-2 ug/mL PA-824?

-0.570

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.518

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.634

Verapamil50 uM Verapamil?

0.420

mercaptoethanol2 mM 2-Mercaptoethanol?

0.542

methoxatin10-20 ug/mL Methoxatin?